Using two separate in vitro expansion protocols, TNFR2 agonism corrected the T1D activation defect by triggering conversion of rTregs into aTregs (n=54 T1D, P<0.001). The gene discussed is TNFRSF1B; the disease is type 1 diabetes mellitus.